Molteni&C

Molteni Farmaceutici is a specialized Italian pharmaceutical company focused on the development and commercialization of treatments for pain management and addiction. Founded in 1892, the company has established itself as a leader in the opioid sector, particularly in the European market. Its portfolio includes a range of analgesic products and innovative treatments for opioid use disorder, such as long-acting buprenorphine formulations. Molteni operates a significant manufacturing facility in Italy and maintains a strong presence in the intensive care and specialist medicine segments. The company also invests in research through its Molteni Therapeutics division, which focuses on PhotoDynamic Therapy for wound care and infections.